Osteoclast-poor human osteopetrosis due to mutations in the gene encoding RANKL.

Article Details

Citation

Sobacchi C, Frattini A, Guerrini MM, Abinun M, Pangrazio A, Susani L, Bredius R, Mancini G, Cant A, Bishop N, Grabowski P, Del Fattore A, Messina C, Errigo G, Coxon FP, Scott DI, Teti A, Rogers MJ, Vezzoni P, Villa A, Helfrich MH

Osteoclast-poor human osteopetrosis due to mutations in the gene encoding RANKL.

Nat Genet. 2007 Aug;39(8):960-2. Epub 2007 Jul 15.

PubMed ID
17632511 [ View in PubMed
]
Abstract

Autosomal recessive osteopetrosis is usually associated with normal or elevated numbers of nonfunctional osteoclasts. Here we report mutations in the gene encoding RANKL (receptor activator of nuclear factor-KB ligand) in six individuals with autosomal recessive osteopetrosis whose bone biopsy specimens lacked osteoclasts. These individuals did not show any obvious defects in immunological parameters and could not be cured by hematopoietic stem cell transplantation; however, exogenous RANKL induced formation of functional osteoclasts from their monocytes, suggesting that they could, theoretically, benefit from exogenous RANKL administration.

DrugBank Data that Cites this Article

Polypeptides
NameUniProt ID
Tumor necrosis factor ligand superfamily member 11O14788Details